|
1
|
Zeng H, Zheng R, Zhang S, Zou X and Chen
W: Female breast cancer statistics of 2010 in China: Estimates
based on data from 145 population-based cancer registries. J Thorac
Dis. 6:466–470. 2014.PubMed/NCBI
|
|
2
|
Youlden DR, Cramb SM, Dunn NA, Muller JM,
Pyke CM and Baade PD: The descriptive epidemiology of female breast
cancer: An international comparison of screening, incidence,
survival and mortality. Cancer Epidemiol. 36:237–248. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen WQ, Zheng RS, Zhang SW, Li N, Zhao P,
Li GL, Wu LY and He J: Report of incidence and mortality in china
cancer registries, 2008. Chin J Cancer Res. 24:171–180. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Galvão ER, Martins LM, Ibiapina JO,
Andrade HM and Monte SJ: Breast cancer proteomics: A review for
clinicians. J Cancer Res Clin Oncol. 137:915–925. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xue YK, Tan J, Dou DW, Chen D, Chen LJ,
Ren HP, Chen LB, Xiong XG and Zheng H: Effect of Kruppel-like
factor 4 on Notch pathway in hepatic stellate cells. J Huazhong
Univ Sci Technolog Med Sci. 36:811–816. 2016.PubMed/NCBI
|
|
6
|
Mahatan CS, Kaestner KH, Geiman DE and
Yang VW: Characterization of the structure and regulation of the
murine gene encoding gut-enriched Krüppel-like factor (Krüppel-like
factor 4). Nucleic Acids Res. 27:4562–4569. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rowland BD and Peeper DS: KLF4, p21 and
context-dependent opposing forces in cancer. Nat Rev Cancer.
6:11–23. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin ZS, Chu HC, Yen YC, Lewis BC and Chen
YW: Correction: Krüppel-like factor 4, a tumor suppressor in
hepatocellular carcinoma cells reverts epithelial mesenchymal
transition by suppressing slug expression. PLoS One.
11:e01541682016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li H, Wang J, Xiao W, Xia D, Lang B, Yu G,
Guo X, Guan W, Wang Z, Hu Z, et al: Epigenetic alterations of
Krüppel-like factor 4 and its tumor suppressor function in renal
cell carcinoma. Carcinogenesis. 34:2262–2270. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao F, Wang K, Zhu R, Hu YW, Fang WZ and
Ding HZ: Clinicopathological significance of reduced SPARCL1
expression in human breast cancer. Asian Pac J Cancer Prev.
14:195–200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bauer KR, Brown M, Cress RD, Parise CA and
Caggiano V: Descriptive analysis of estrogen receptor
(ER)-negative, progesterone receptor (PR)-negative, and
HER2-negative invasive breast cancer, the so-called triple-negative
phenotype: A population-based study from the California cancer
registry. Cancer. 109:1721–1728. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Evans PM and Liu C: Roles of Krüpel-like
factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim
Biophys Sin (Shanghai). 40:554–564. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yet SF, McA'Nulty MM, Folta SC, Yen HW,
Yoshizumi M, Hsieh CM, Layne MD, Chin MT, Wang H, Perrella MA, et
al: Human EZF, a Krüppel-like zinc finger protein, is expressed in
vascular endothelial cells and contains transcriptional activation
and repression domains. J Biol Chem. 273:1026–1031. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoon HS, Chen X and Yang VW: Kruppel-like
factor 4 mediates p53-dependent G1/S cell cycle arrest in response
to DNA damage. J Biol Chem. 278:2101–2105. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yori JL, Johnson E, Zhou G, Jain MK and
Keri RA: Kruppel-like factor 4 inhibits epithelial-to-mesenchymal
transition through regulation of E-cadherin gene expression. J Biol
Chem. 285:16854–16863. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei D, Gong W, Kanai M, Schlunk C, Wang L,
Yao JC, Wu TT, Huang S and Xie K: Drastic down-regulation of
Krüppel-like factor 4 expression is critical in human gastric
cancer development and progression. Cancer Res. 65:2746–2754. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi BJ, Cho YG, Song JW, Kim CJ, Kim SY,
Nam SW, Yoo NJ, Lee JY and Park WS: Altered expression of the KLF4
in colorectal cancers. Pathol Res Pract. 202:585–589. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ohnishi S, Ohnami S, Laub F, Aoki K,
Suzuki K, Kanai Y, Haga K, Asaka M, Ramirez F and Yoshida T:
Downregulation and growth inhibitory effect of epithelial-type
Krüppel-like transcription factor KLF4, but not KLF5, in bladder
cancer. Biochem Biophys Res Commun. 308:251–256. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu W, Hofstetter WL, Li H, Zhou Y, He Y,
Pataer A, Wang L, Xie K, Swisher SG and Fang B: Putative
tumor-suppressive function of Kruppel-like factor 4 in primary lung
carcinoma. Clin Cancer Res. 15:5688–5695. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen YJ, Wu CY, Chang CC, Ma CJ, Li MC and
Chen CM: Nuclear Krüppel-like factor 4 expression is associated
with human skin squamous cell carcinoma progression and metastasis.
Cancer Biol Ther. 7:777–782. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tai SK, Yang MH, Chang SY, Chang YC, Li
WY, Tsai TL, Wang YF, Chu PY and Hsieh SL: Persistent Krüppel-like
factor 4 expression predicts progression and poor prognosis of head
and neck squamous cell carcinoma. Cancer Sci. 102:895–902. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Foster KW, Liu Z, Nail CD, Li X,
Fitzgerald TJ, Bailey SK, Frost AR, Louro ID, Townes TM, Paterson
AJ, et al: Induction of KLF4 in basal keratinocytes blocks the
proliferation-differentiation switch and initiates squamous
epithelial dysplasia. Oncogene. 24:1491–1500. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wei D, Wang L, Kanai M, Jia Z, Le X, Li Q,
Wang H and Xie K: KLF4α up-regulation promotes cell cycle
progression and reduces survival time of patients with pancreatic
cancer. Gastroenterology. 139:2135–2145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rakha EA, Reis-Filho JS, Baehner F, Dabbs
DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani
SR, et al: Breast cancer prognostic classification in the molecular
era: The role of histological grade. Breast Cancer Res. 12:2072010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yori JL, Seachrist DD, Johnson E, Lozada
KL, Abdul-Karim FW, Chodosh LA, Schiemann WP and Keri RA:
Krüppel-like factor 4 inhibits tumorigenic progression and
metastasis in a mouse model of breast cancer. Neoplasia.
13:601–610. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moon JS, Kim HE, Koh E, Park SH, Jin WJ,
Park BW, Park SW and Kim KS: Krüppel-like factor 4 (KLF4) activates
the transcription of the gene for the platelet isoform of
phosphofructokinase (PFKP) in breast cancer. J Biol Chem.
286:23808–23816. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen ZY, Wang X, Zhou Y, Offner G and
Tseng CC: Destabilization of Krüppel-like factor 4 protein in
response to serum stimulation involves the ubiquitin-proteasome
pathway. Cancer Res. 65:10394–10400. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cullingford TE, Butler MJ, Marshall AK, el
L Tham, Sugden PH and Clerk A: Differential regulation of
Krüppel-like factor family transcription factor expression in
neonatal rat cardiac myocytes: Effects of endothelin-1, oxidative
stress and cytokines. Biochim Biophys Acta. 1783:1229–1236. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen ZY, Shie J and Tseng C: Up-regulation
of gut-enriched krüppel-like factor by interferon-gamma in human
colon carcinoma cells. FEBS Lett. 477:67–72. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wei D, Kanai M, Huang S and Xie K:
Emerging role of KLF4 in human gastrointestinal cancer.
Carcinogenesis. 27:23–31. 2006. View Article : Google Scholar : PubMed/NCBI
|
